منابع مشابه
A case of aortic valve replacement with St. Jude Medical Regent valve (first implant in Japan).
The St. Jude Medical (SJM) Regent valve was developed as a new mechanical valve by improving the conventional SJM valve. The effective orifice area is wider than that of Hemodynamic Plus (HP) series. The efficacy of the new valve has been reported in Europe and the United States. On October 26, 2004, we first performed aortic valve replacement (AVR) with the SJM Regent valve for aortic valve st...
متن کاملOn-X versus St Jude Medical Regent mechanical aortic valve prostheses: early haemodynamics
OBJECTIVE We aimed to compare the early haemodynamic data of the On-X and St Jude Medical (SJM) Regent bileaflet mechanical prostheses in the aortic position. METHODS A retrospective study was performed using data collected prospectively for a national database. Thirty-three patients who had aortic On-X valve (On-X group) and 33 matched patients who had aortic SJM Regent valve (SJM group) wer...
متن کاملSeventeen-millimeter St. Jude Medical Regent valve in patients with small aortic annulus: dose moderate prosthesis-patient mismatch matter?
BACKGROUND The study was designed to evaluate the effects of moderate prosthesis-patient mismatch (defined as 0.65 cm(2)/m(2) <indexed effective orifice area ≤ 0.85 cm(2)/m(2)) on midterm outcomes after isolated aortic valve replacement with a 17-mm St. Jude Medical Regent valve in a large series of patients, and to determine if these effects are influenced by patient confounding variables. M...
متن کاملLong-term outcomes after St. Jude Medical mechanical valve implantation.
patient-year), major bleeding events (1.0%/patient-year), and aortic valve reoperation (0.26%/patient-year). They also reported that valve-related death was the most common cause of death (26.8%) and that the rates of freedom from valve-related death were 96.2%, 92.7%, 88.8%, and 86.6% at 5, 10, 15, and 20 years, respectively. These results compare favorably with the findings of previous report...
متن کاملThe St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
BACKGROUND From October 1977 to October 2002, 4,480 patients (age range, 17 to 94 years; average, 64 +/- 13 years) underwent single valve replacement with the St. Jude Medical heart valve. Of 2,982 aortic (AVR) and 1,498 mitral valve replacements (MVR), concomitant coronary artery bypass grafting was performed on 42% and 33%, respectively. METHODS Cardiac Surgical Associates has maintained an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Thoracic and Cardiovascular Surgery
سال: 2006
ISSN: 0022-5223
DOI: 10.1016/j.jtcvs.2005.08.067